<DOC>
	<DOCNO>NCT02080143</DOCNO>
	<brief_summary>A disposable , air-activated , adhesive back heat patch evaluate .</brief_summary>
	<brief_title>A Comparative Study Evaluate Two Air-Activated Adhesive Backed Heat Patches</brief_title>
	<detailed_description />
	<criteria>Subjects complete appropriately administer informed consent process include sign IRBapproved consent form ; subject 1875 year old sex ; skin type race , provide skin pigmentation allow discernment erythema ; subject good general health free disease state physical condition ; subject willing able study product apply direct , comply study instruction ; subject must willing restrict activity 8 hour patch wear time patch thermocouple come loose ; subject must willing wear pouch contain thermologger thermocouple wire entire 8 hour ; subject 55 year old agree wear tshirt provide site entire 8 hour patch wear time . Subjects pregnant nursing ; subject excessive hair application site , scar tissue , tattoo coloration would interfere placement study product skin assessment ; subject diabetes poor circulation clinically significant chronic illness could place subject increase risk participation result inappropriate dermal response study ; subject unable feel pain heat ( e.g. , subject neuropathy ) ; subject active dermatitis ( include sunburn ) treatment area visible dermatological disease , investigator 's opinion , might interfere response study product interfere skin assessment associate study product ; history significant dermatologic cancer neoplasms treatment area ; subject use topical dermatological product application area within 24 hour prior anticipate study product application ; subject use concomitant medication , investigator 's opinion , could interfere interpretation study result . Examples drug include vasoactive ( constrictor dilator ) medication , prescription OTC , could modulate blood flow , within 24 hour prior application study product , include nitroglycerin , nonsteroidal antiinflammatory product ( NSAIDs , e.g. , ibuprofen , aspirin ( &lt; =81 mg/day acceptable ) ) , topical corticosteroid OTC cough/cold product include antihistamine and/or either phenylpropanolamine phentolamine ; subject use systemic steroid ( i.e. , oral , IV , IM intraarticular ) 30 day prior application test article ( intranasal/inhaled steroid acceptable ) ; subject receive investigational medication device within 30 day prior enrollment study ; subject history sensitivity study product adhesion material ; subject currently participate investigational study ; subject know noncompliant unlikely comply requirement study protocol ( e.g. , due alcoholism , product dependency , mental incapacity ) opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Skin temperature measurement</keyword>
	<keyword>Heat patch adhesion</keyword>
	<keyword>Dermal irritation</keyword>
</DOC>